KR20030021640A - Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof - Google Patents
Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof Download PDFInfo
- Publication number
- KR20030021640A KR20030021640A KR1020010055000A KR20010055000A KR20030021640A KR 20030021640 A KR20030021640 A KR 20030021640A KR 1020010055000 A KR1020010055000 A KR 1020010055000A KR 20010055000 A KR20010055000 A KR 20010055000A KR 20030021640 A KR20030021640 A KR 20030021640A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- column
- antioxidant
- fraction
- activity
- Prior art date
Links
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 48
- 239000000284 extract Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title description 2
- 241001520913 Phyllostachys edulis Species 0.000 title 1
- 235000003570 Phyllostachys pubescens Nutrition 0.000 title 1
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 16
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 11
- 238000004440 column chromatography Methods 0.000 claims abstract description 7
- 238000010992 reflux Methods 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 36
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 36
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 36
- 241001330002 Bambuseae Species 0.000 claims description 35
- 239000011425 bamboo Substances 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002034 butanolic fraction Substances 0.000 claims description 7
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 230000000274 adsorptive effect Effects 0.000 claims description 4
- 238000002523 gelfiltration Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000012869 ethanol precipitation Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 15
- 239000001301 oxygen Substances 0.000 abstract description 15
- 229910052760 oxygen Inorganic materials 0.000 abstract description 15
- 230000002000 scavenging effect Effects 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 230000032683 aging Effects 0.000 abstract description 7
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 3
- 241000745988 Phyllostachys Species 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 2
- 229940093499 ethyl acetate Drugs 0.000 abstract 1
- 235000019439 ethyl acetate Nutrition 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 235000006708 antioxidants Nutrition 0.000 description 34
- 230000003859 lipid peroxidation Effects 0.000 description 15
- 230000007760 free radical scavenging Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 10
- 239000000469 ethanolic extract Substances 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 6
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000209128 Bambusa Species 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000002044 hexane fraction Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 210000001589 microsome Anatomy 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SLUKQUGVTITNSY-UHFFFAOYSA-N 2,6-di-tert-butyl-4-methoxyphenol Chemical compound COC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SLUKQUGVTITNSY-UHFFFAOYSA-N 0.000 description 1
- SENUUPBBLQWHMF-UHFFFAOYSA-N 2,6-dimethylcyclohexa-2,5-diene-1,4-dione Chemical compound CC1=CC(=O)C=C(C)C1=O SENUUPBBLQWHMF-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001237160 Kallima inachus Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 244000302661 Phyllostachys pubescens Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
Description
본 발명은 항산화활성이 있는 맹종죽엽의 추출물 및 그 제조방법에 관한 것이다. 더욱 상세하게는 맹종죽엽을 유기용매로 추출하고 컬럼크로마토그래피 및 박층크로마토그래피를 이용하여 정제한 항산화 활성이 있는 맹종죽엽의 추출물 및 그 제조방법에 관한 것이다.The present invention relates to an extract of the dead bamboo leaf with antioxidant activity and a method for producing the same. More particularly, the present invention relates to an extract of an antioxidant activity with an antioxidant activity and a method for producing the same, which are extracted using an organic solvent and purified using column chromatography and thin layer chromatography.
인간을 포함한 모든 호기성 생물체는 산소(O2)를 이용하여 에너지 대사를 진행하며 생존하고 있다. 그러나, 생체내 산소가 각종 물리적, 화학적, 생물학적인스트레스를 받으면 수퍼옥사이드 음이온 라디칼(superoxide anion radical, ·O2), 과산화수소(H2O2), 히드록시 라디칼(hydroxyl radical, ·OH) 등의 유해한 활성산소종(active oxygen species)으로 변하여 인체에 치명적인 생리적 장애를 일으키고 심할 경우는 질병을 유발하고 생명을 잃게 한다. 특히 세포가 나이가 들어감에 따라 자유라디칼 및 활성산소종에 의한 유해작용이 계속적으로 누적될 경우 발암, 동맥경화, 심장질환및 피부노화 등 연령증가에 따른 여러 성인병과 관련된 질환은 물론 전반적인 세포의 노화를 야기하여 인간의 질병발생과 노화의 원인으로 제시되고 있다(Harman, D., Free Radicals in Biology, Academic Press, New York, 255-275(1982)).All aerobic organisms, including humans, survive through energy metabolism using oxygen (O 2 ). However, when oxygen in vivo undergoes various physical, chemical and biological stresses, superoxide anion radical (O 2 ), hydrogen peroxide (H 2 O 2 ), hydroxy radical (OH), etc. It turns into harmful active oxygen species, causing fatal physiological disorders in the human body and, in severe cases, causing disease and losing life. In particular, if the harmful effects of free radicals and free radicals continue to accumulate as the cells age, diseases related to various adult diseases such as carcinogenesis, arteriosclerosis, heart disease, and skin aging, as well as the overall aging of cells It has been suggested as a cause of human disease occurrence and aging (Harman, D., Free Radicals in Biology, Academic Press, New York, 255-275 (1982)).
따라서 최근 노화와 성인병 질환의 원인으로 밝혀진 프리라디칼 및 활성산소종를 조절할 수 있는 물질로 알려진 항산화제의 개발연구가 활발히 진행되어 수퍼옥사이드 디스뮤타아제(superoxide dismutase), 퍼옥시다아제(peroxidase), 카탈라아제(catalase), 글루타티온 퍼옥시다아제(glutathione peroxidase) 등의 항산화효소와 토코페롤(tocopherol), 아스코베이트(ascorbate), 카로테노이드 (carotenoid), 글루타티온(glutathione) 등의 천연물 유래의 저분자 항산화 물질에 대한 많은 연구가 이루어지고 있으며(Chang, S. S., et al., J. Food Sci. 42: 1102, 1977;Hammerschmidt, P. A. and Pratt, D. E., J. Food Sci. 43: 556, 1977; Pratt, D. E. and Watts, B. W., J. Food Sci.29: 17, 1964), 2,6'-디-테르트-부틸-4-히드록시 톨루엔(2,6'-di-tert-butyl-4-hydroxytoluene,BHT), 2,6'-디-테르트-부틸-4-히드록시 아니졸(2,6-di-tert-butyl-4-hydroxyanisole, BHA) 등의 합성 항산화제가 많이 개발되어 의약품과 식품분야에서 이용되고 있다(Kitahara, K., et al., Chem. Pharm. Bull. 40: 2208, 1992; Hatano, T., Natural Medicines 49: 357,1995; Masaki, H., et al., Biol. Pharm. Bull. 18: 162, 1995).As a result, research into the development of antioxidants known to control free radicals and reactive oxygen species, which have been identified as the cause of aging and geriatric diseases, has been actively conducted, and superoxide dismutase, peroxidase, and catalase have been developed. ), Many studies have been conducted on antioxidants such as glutathione peroxidase and low molecular weight antioxidants derived from natural products such as tocopherol, ascorbate, carotenoid, and glutathione. (Chang, SS, et al., J. Food Sci. 42: 1102, 1977; Hammerschmidt, PA and Pratt, DE, J. Food Sci. 43: 556, 1977; Pratt, DE and Watts, BW, J. Food Sci. 29: 17, 1964), 2,6'-di-tert-butyl-4-hydroxy toluene (2,6'-di-tert-butyl-4-hydroxytoluene, BHT), 2,6'- Di-tert-butyl-4-hydroxyanisole (2,6-di-tert-butyl-4-hydroxyanisole, BHA), etc. Many synthetic antioxidants have been developed and used in medicine and food (Kitahara, K., et al., Chem. Pharm. Bull. 40: 2208, 1992; Hatano, T., Natural Medicines 49: 357,1995; Masaki , H., et al., Biol. Pharm. Bull. 18: 162, 1995).
상기 합성항산화제인 부틸히드록시아니솔 (BHA)과 부틸히드록시톨루엔 (BHT)은 항산화력은 비교적 우수하나 인체독성문제로 사용량과 용도가 엄격하게 제한되어 있다. 따라서 천연물로부터 항산화활성이 높으며, 인체의 해가 없는 항산화제를 찾고자 하는 시도가 활발히 진행중이다. 그 예로 녹차잎의 카테친 계열 화합물 (Nanjo, F.; Goto, K.; Seto, R.; Suzuki, M.; Hara, Y. Free Radic. Biol. Med. 21: 895-902, 1996), 당근의 베카 카로틴 계열 화합물이 잘 알려져 있으며, 국내의 경우 본 발명자들에 의하여 냉이로부터 분리한 플라본계열의 항산화성 물질등이 연구되었으나 (Kweon, M.H.; Kwak, J.H.; Sung, H.C.; Yang, H.C. J. Biochem. Mol. Chem. 29: 423-428, 1996) 상업화 되지는 못하였다.Butyl hydroxy anisole (BHA) and butyl hydroxytoluene (BHT), the synthetic antioxidants are relatively excellent in antioxidant capacity, but their usage and use are strictly limited. Therefore, there is an active attempt to find an antioxidant that is high in natural products and does not harm the human body. For example, catechin family compounds of green tea leaves (Nanjo, F .; Goto, K .; Seto, R .; Suzuki, M .; Hara, Y. Free Radic. Biol. Med. 21: 895-902, 1996), carrots Beca carotene-based compounds of the well-known, in the case of domestic flavone-based antioxidants isolated from the was studied by the present inventors (Kweon, MH; Kwak, JH; Sung, HC; Yang, HCJ Biochem. Mol. Chem. 29: 423-428, 1996).
따라서 본 발명자들은 새로운 천연 항산화제를 개발하고자 연구를 하던 중, 우리나라에서 주로 서식하는 대나무의 한종류인 맹종죽의 잎부위 추출물에 유리라디컬 및 활성산소 소거활성과 지질과산화 억제활성이 우수한 항산화성분이 다량 함유되어 있음을 발견하였다.Therefore, the present inventors, while researching to develop a new natural antioxidant, a large amount of antioxidants excellent in free radicals and free radical scavenging activity and lipid peroxidation inhibitory activity in the extract of the leaves of the bamboo shoots, one of the bamboos inhabiting in Korea It was found to contain.
대나무는 아열대 및 온대지방까지 널리 분포하며, 특히 아시아의 계절풍지대에 흔히 자생하는 벼과에 속하는 상록교목으로, 우리나라에는 왕대, 솜대, 맹종죽의 3대 죽종이 주류를 이루고 있으며 주로 남부지방에서 재배되고 있다. 왕대와 솜대는 식용보다는 가구제조등에 주로 이용된다. 맹종죽 (孟宗竹)은 일본에서는 직경이 약 20cm 정도가 되는 것이 있을 정도로 대나무 중에서 가장 굵어질 수 있는 것으로, 가구제조에도 이용되나 죽순이 굵고, 먹을 수 있기 때문에 식용죽 (食用竹)이라고 흔히 부르고, 죽순과 목재에 이용되는 부분 이외인 맹종죽엽은 모두 폐기되고 있는 실정이다.또한 맹종죽은 예로부터 구토, 소염, 유산, 발한, 중품 등에 대한 치료제로 이용되어 왔고 (동의보감, 중약대사전) 그외에 항균성을 나타내는 물질이 함유되어 있어 일본에서는 옛부터 죽물통으로 이용하였고, 우리나라에서도 고기, 경단등을 포장하는 식품의 보관에 이용되어 왔다.Bamboo is widely distributed in subtropical and temperate regions. Especially, bamboo is an evergreen tree belonging to the genus Japonica, which is common in Asian monsoon zones. Bamboo is mainly cultivated in the southern part of Korea. . Kings and cotton pads are used for furniture, rather than food. Mengjongjuk (孟宗竹) is the thickest among bamboos, with a diameter of about 20cm in Japan. It is also used for making furniture, but it is commonly called edible bamboo because it is thick and can be eaten. In addition to the parts used for wood, all the dead leaves are discarded. In addition, the dead leaves have been used as a treatment for vomiting, anti-inflammatory, miscarriage, sweating, and intermediates (consent of consent, Chinese herbal medicine dictionary) and other substances that exhibit antimicrobial properties. It has been used as a bamboo container in Japan since ancient times, and has been used in food storage for meat and dumplings in Korea.
종래 맹종죽을 비롯한 대나무의 생리활성 물질 연구는 대부분 항균활성 중심으로 국내 및 일본에서 보고 되어왔다. 이미 대나무 잎에서 항균성 물질인 2,6-디메틸벤조퀴논과 벤조산이 일본 연구자에 의하여 밝혀져 있다. 국내의 경우 아직, 물질의 규명단계에 접근한 연구 보다 죽엽의 용매 추출물에 대하여 항균활성의 조사 (김미정등, 한국영양식량학회지, 25권 1호, p.135-142, 1996) 와 죽순의 일반 성분 분석에 관한 보고 (정종성등, 한국임학회지, 78권 1호, p,55-60, 1989) 등 매우 제한된 연구가 보고되었다. 또한, 대나무의 죽간(竹桿), 죽엽(竹葉) 또는 이들의 혼합물로부터 추출한 대나무추출액을 이용하여 육류재료의 이취를 제거하고 육류의 맛을 증진시킬 수 있는 육류제품 가공방법( 대한민국 공개번호 제 98-082956호), 단순히 죽엽가루나 죽엽추출물 (대나무의 종이나 서식지 불분명)을 식품에 첨가하여 식품의 품질향상을 기하는 국내특허 (대한민국 공개번호 제2000-074538)들이 존재하나, 주로 폐기되고 있는 맹종죽의 엽부위 추출물이 항산화활성이 있다는 것은 본 발명자들에 의해 처음 밝혀진 것이다.Most studies on bioactive substances of bamboo including bamboo shoots have been reported in Korea and Japan mainly on antibacterial activity. Already, 2,6-dimethylbenzoquinone and benzoic acid, which are antimicrobial substances in bamboo leaves, have been identified by Japanese researchers. In Korea, the antimicrobial activity of bamboo leaf extracts (Kim Mi-Jung et al., Korean Journal of Nutrition and Nutrition, Vol. 25 No. 1, p.135-142, 1996) and the general characteristics of bamboo shoots Very limited studies have been reported, including reports on component analysis (Jung Jong Sung et al., Korean Journal of Forestry, vol. 78, No. 1, p. 55-60, 1989). In addition, using a bamboo extract extracted from bamboo bamboo bamboo, bamboo leaves or a mixture thereof, a meat product processing method that can remove the off-flavor of meat material and enhance the taste of meat (Korean Publication No. 98-082956), there is a domestic patent (Korean Publication No. 2000-074538) that improves the quality of food by simply adding bamboo leaf powder or bamboo leaf extract (paper of bamboo or habitat unknown), but it is mainly discarded. It was first discovered by the present inventors that the leaf extracts of the bamboo shoots have antioxidant activity.
따라서 본 발명의 목적은 항산화활성이 있는 맹종죽엽 추출물을 제공함에 있다. 본 발명의 다른 목적은 상기 항산화활성이 있는 맹종죽엽 추출물의 제조방법을 제공함에 있다.Therefore, it is an object of the present invention to provide an extract of the dead leaves of antioxidant. It is another object of the present invention to provide a method for preparing the extracts of the Blind bamboo leaf having the antioxidant activity.
본 발명은 맹종죽엽을 동결건조하여 파쇄 및 분말화한 다음 에탄올로 추출하고, 헥산, 클로로포름, 에틸아세테이트, 부탄올을 순차적으로 이용하여 유기용매 분배 분획을 한뒤, 컬럼크로마토그라피와 박층크로마토그라피를 이용하여 정제한 맹종죽엽 추출물의 유리라디컬 소거활성, 활성산소 소거능 측정, 지질과산화 저해활성을 측정하여 항산화활성을 확인함으로써 완성하였다.The present invention is lyophilized by lyophilization and then crushed and powdered, extracted with ethanol, and then hexane, chloroform, ethyl acetate, butanol using an organic solvent partitioned fractions sequentially, using column chromatography and thin layer chromatography The free radical scavenging activity, free radical scavenging activity, and lipid peroxidation inhibitory activity of the purified bamboo blind leaf extract were measured.
이하, 본 발명의 구성 및 작용을 설명한다.Hereinafter, the configuration and operation of the present invention.
도 1은 본 발명 맹종죽엽의 에탄올 추출물 및 유기용매 분배분획물의 항산화활성을 나타낸 그래프이다.1 is a graph showing the antioxidant activity of the ethanol extract and organic solvent fraction of the present invention.
본 발명에 의한 제조방법은 맹종죽엽을 수세한 후 동결건조 또는 음건한 다음 파쇄하여 수득한 건조분말을 70% 에탄올을 이용하여 80±2℃에서 환류추출하는 단계; 상기 추출물을 에탄올 침전을 실시하여 고분자성 화합물을 제거한 후, 극성을 달리하는 헥산, 크로로포름, 에틸아세테이트, 부탄올을 이용하여 순차적으로 분배분획하는 단계; 상기추출물을 증류수에 용해하여 흡착성 HP-20컬럼, 극성 실리카겔 컬럼, LH-20 겔여과컬럼, ODS 역상컬럼 크로마토그라피의 4 단계 컬럼크로마토그라피 정제단계; 상기 컬럼 정제 활성획분을 메탄올에 용해한 후 최종적으로 순상 및 역상의 박층크라마토그라피에 의한 정제단계를 포함한다.The manufacturing method according to the present invention comprises the steps of reflux extraction at 80 ± 2 ° C. using 70% ethanol after lyophilizing or drying and crushing the dead bamboo leaves after crushing; Ethanol precipitation of the extract to remove the polymeric compound, and then sequentially partitioning fractions using hexane, chloroform, ethyl acetate, butanol with different polarities; Dissolving the extract in distilled water to purify the column with four steps of adsorptive HP-20 column, polar silica gel column, LH-20 gel filtration column, ODS reversed phase chromatography; The column purification active fractions are dissolved in methanol and finally purified by thin layer chromatography followed by normal and reverse phases.
상기 방법의 각 단계에서 수득되는 획분들에 대하여 1,1-디페닐-2-피크릴하이드라질 (DPPH) 유리라디컬에 대한 소거활성, 잔틴 (xanthine)과 잔틴옥시다제 (xanthine oxidase)를 이용하여 생성시킨 활성산소 즉 수퍼옥사이드의 소거활성과 흰쥐 간에서 분리한 마이크로좀 내의 지질과산화 저해활성을 측정한 결과 각 분획물들이 항산화활성이 있음이 확인되었으며, 최종 정제 맹종죽엽 추출물의 항산화활성은 종래의 항산화제들과 비교 조사한 결과 그 활성이 더 우수함을 확인하였다.Scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals, xanthine and xanthine oxidase, for fractions obtained in each step of the process As a result of measuring the scavenging activity of the active oxygen generated by the superoxide and the lipid peroxidation inhibitory activity in the microsomes isolated from the rat liver, it was confirmed that each fraction has antioxidant activity. A comparative study with antioxidants showed that the activity was better.
따라서, 상기 맹종죽엽의 건조분말을 에탄올을 이용하여 환류추출, 농축 및 건조하면 수용성 암갈색 추출물을 얻을 수 있는바, 이는 DPPH 유리라디컬 및 활성산소 활성과 지질과산화 저해활성을 가지고 있어 항산화용 조성물로 사용할 수 있다.Therefore, the refractory extract, concentrate and dry the dried powder of the bamboo shoots with ethanol to obtain a water-soluble dark brown extract, which has DPPH free radicals and active oxygen activity and lipid peroxidation inhibitory composition as an antioxidant composition Can be used.
또한 상기 에탄올추출물을 에탄올 침전을 실시하여 고분자성 화합물을 제거한 후, 극성을 달리하는 유기용매들을 이용하여 순차적으로 분배분획하고, 활성이 가장 높은 부탄올 획분에 대하여 용매제거, 동결건조한 수용성 갈색 분말을 얻을 수 있는 바, 이도 항산화용 조성물로 사용할 수 있다.In addition, the ethanol extract is subjected to ethanol precipitation to remove the polymeric compound, and then sequentially partitioned and fractionated using organic solvents having different polarities, and solvent-soluble and lyophilized water-soluble brown powder is obtained for the highest active butanol fraction. It can also be used as an antioxidant composition.
또한 상기 부탄올획분인 갈색분말을 증류수에 용해하여 흡착성 HP-20컬럼, 극성 실리카겔 컬럼, LH-20 겔여과컬럼, ODS 역상컬럼 크로마토그라피 의 4 단계 정제를 통해 수득된 수용성 미황색 분말도 항산화용 조성물로 사용할 수 있다.In addition, the water-soluble pale yellow powder obtained by dissolving the brown powder, which is the butanol fraction in distilled water, through four-stage purification of an adsorptive HP-20 column, a polar silica gel column, an LH-20 gel filtration column, and an ODS reversed phase column chromatography was also used as an antioxidant composition. Can be used.
그리고 상기 컬럼 정제 미황색분말을 메탄올에 용해한 후 최종적으로 순상 및 역상의 박층크라마토그라피를 순차적으로 실시하고 강력한 활성을 나타내는 분리밴드를 취하고 메탄올에 활성물질을 용출시킨 다음 잔존의 용출액 내 실리카겔을 원심분리 및 여과을 통하여 제거한 후 농축, 동결건조한 수용성 유백색 분말을 항산화용 조성물로 사용할 수 있다.After dissolving the column-purified slightly yellow powder in methanol, finally performing thin layer chromatography of the normal phase and reverse phase, taking a separation band showing strong activity, eluting the active substance in methanol, and centrifuging the silica gel in the remaining eluate. And after removal through filtration concentrated and lyophilized water-soluble milky white powder can be used as an antioxidant composition.
또한 본 발명에서의 맹종죽엽 유래의 항산화용 조성물은 상기 전단계의 추출물질들을 모두 포함한다.In addition, the antioxidant composition derived from the stem of the present invention includes all the extracts of the previous step.
본 발명에 의한 맹종죽엽 추출물은 종래의 천연항산화제는 물론 합성항산화제 보다도 항산화 효과가 탁월한 것으로 나타났다. 따라서 본 발명에 의한 맹종죽엽 추출물을 함유하는 항산화용 조성물은 노화와 성인병 질환을 예방, 치료하기 위한 약학적 조성물 또는 기능성 식품 및 화장품으로 사용될 수 있다. 또한 맹종죽엽은 오랫동안 생약 및 식용으로 쓰여왔던 것이므로 이들로부터 추출된 본 발명의 추출물 역시 독성 및 부작용 등의 문제가 없을 것임을 예상할 수 있다.The blind bamboo leaf extract according to the present invention was shown to have an excellent antioxidant effect as compared to the conventional natural antioxidants as well as synthetic antioxidants. Therefore, the composition for antioxidants containing the extracts of the stem of the present invention can be used as a pharmaceutical composition or functional food and cosmetics for preventing and treating aging and geriatric diseases. In addition, since the dead bamboo leaf has been used for a long time as a herbal medicine and edible extract of the present invention can be expected that there will be no problems such as toxicity and side effects.
이하, 본 발명의 구체적인 구성 및 작용을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific configuration and operation of the present invention will be described in detail by way of examples, but the scope of the present invention is not limited only to these embodiments.
실시예 1 : 맹종죽엽 항산화 추출물의 제조Example 1 Preparation of Bacterium Leaf Antioxidant Extract
본 발명에서 사용되는 맹종죽엽은 대한민국 거제도 하청면 일대에 서식하는 맹종죽의 잎으로, 이를 채취하여 수세하고 동결건조 또는 음건 후 파쇄하여 분말화하여 사용하고, 항산화활성이 있는 추출물은 상기와 같이 제조한다.Bamjongjuk leaf used in the present invention is a leaf of Bamjongjuk inhabiting Hacheongmyeon, Geoje-do, Korea, collected and washed with water, lyophilized or crushed after drying, and used as an extract.
실험예 1 : 맹종죽엽의 에탄올추출Experimental Example 1 Ethanol Extraction of the
상기 맹종죽엽 건조분말 500 g을 5 L 부피의 원형 바닥 플라스크에 넣고 3 L의 70% 에탄올을 가하여 80±2℃에서 6 시간 환류추출의 과정을 3회 내지 4회 반복 실시하여 약 10 L의 추출액을 수득한 후 원심분리 (4℃, 5000 rpm, 25 분) 및 감압필터 하여 추출잔사를 제거하였다. 여과액을 회전증발감압농축기를 사용하여 용매를 제거하고 동결건조하여 약 90 g의 항산화성 추출물을 얻었다.500 g of the dried bamboo leaf powder was added to a 5 L volume round bottom flask, and 3 L of 70% ethanol was added to the mixture at 80 ± 2 ° C. for 6 hours at reflux for 3 to 4 times to extract about 10 L of extract. The obtained residue was removed by centrifugation (4 ° C, 5000 rpm, 25 minutes) and reduced pressure filter. The filtrate was removed using a rotary evaporation pressure reducer and lyophilized to obtain about 90 g of antioxidant extract.
실험예 2 : 맹종죽엽의 유기용매 분배분획Experimental Example 2: Organic Solvent Distribution of
상기 실험예 1에서의 추출물을 1 L의 증류수에 용해시킨 후 3L의 차가운 95% 에탄올를 가하여 교반하고 4℃에서 12시간 정치한다. 이 과정에서 생긴 침전물을 원심분리 (4℃, 6000 rpm, 30 분) 및 감압필터 여과로 제거하고, 여과액을 감압건조하여 에탄올을 완전 제거한 액을 증류수 2 L에 재용해 시킨다. 그리고 5 L 부피의 분액깔대기에 2 L의 n-헥산를 혼합하여 헥산층과 수층으로 2회 분획하였다. 상기 수층에 2 L의 클로로포름을 첨가하여 클로로포름층과 수층으로 2회 분획하고, 수층에 다시 에틸아세테이트를 첨가하고 에틸아세테이트층과 수층으로 2회 분획하고, 최종적으로 수층에 n-부탄올을 2 L 가하여 부탄올층과 수층으로 2회 분획하였다.After dissolving the extract in Experimental Example 1 in 1 L of distilled water, 3 L of cold 95% ethanol was added thereto, stirred, and left to stand at 4 ° C for 12 hours. The precipitate produced in this process is removed by centrifugation (4 ° C., 6000 rpm, 30 minutes) and reduced pressure filter filtration, and the filtrate is dried under reduced pressure and redissolved in 2 L of distilled water. Then, 2 L of n-hexane was mixed in a 5 L separatory funnel, and the resultant was separated twice into a hexane layer and an aqueous layer. 2 L of chloroform was added to the aqueous layer, and the mixture was partitioned twice into a chloroform layer and an aqueous layer, and ethyl acetate was further added to the aqueous layer, twice separated into an ethyl acetate layer and an aqueous layer, and 2 L of n-butanol was finally added to the aqueous layer. Fraction was performed twice with butanol layer and aqueous layer.
상기에서 얻은 각 분획을 감압건조하여 각 유기용매를 제거한 뒤 동결건조한 결과 헥산획분 클로로포름획분, 에틸아세테이트획분, 부탄올획분, 최종수층획분을 각각 15.2 g, 6.9 g, 2.1 g, 9.3 g, 16.1 g씩 얻었다.Each fraction obtained above was dried under reduced pressure to remove each organic solvent, followed by lyophilization. As a result, 15.2 g, 6.9 g, 2.1 g, 9.3 g, and 16.1 g of hexane fraction, ethyl acetate fraction, butanol fraction, and final aqueous layer fraction were obtained. Got it.
실험예 3 : 컬럼크로마토그래피 정제Experimental Example 3: Column Chromatography Purification
상기 실험예 2의 n-부탄올 획분 (9.3 g)을 50 mL 알칼리수 (pH 10)에 용해시켜 흡착성 디아이온 HP-20 레진이 충진된 첫 번째 컬럼 (4 x 28 cm) 상단부위에 흡착시킨 후 30% 메탄올로 용출시킨 활성획분 2.2 g을 극성 실리카겔이 충진된 두 번째 컬럼 (5 x 12 cm)에서 메탄올을 농도구배로 증가시킨 클로로포름 용매를 이용하여 용출시킨다. 그리고 상기 활성획분을 감압건조 후 1 mL의 메탄올에 용해하고, 저분자용 겔여과 세파덱스 (Sephadex) LH-20이 충진된 세 번째 컬럼 (2 x 95 cm)에 도입하여 95% 메탄올을 유속 0.2 mL/분 으로 하여 4 mL 씩 분획하였다. 상기과정의 활성획분 (48번 - 60번 튜브)들을 혼합농축하여 소수성 옥타데실실란 (ODS)이 충진된 네 번째 컬럼 (1.5 x 8.5 cm)에 도입시키고 30 ∼ 70% 메탄올의 농도구배로 유속 0.1 mL/min 하에 2 mL 씩 분획하여 강력한 항산화성 활성획분 (10번 - 18번 튜브) 357 mg을 수득하였다.The n-butanol fraction (9.3 g) of Experimental Example 2 was dissolved in 50 mL of alkaline water (pH 10) and adsorbed onto the upper part of the first column (4 x 28 cm) filled with adsorptive diion HP-20 resin. 2.2 g of the active fraction eluted with% methanol is eluted in a second column (5 x 12 cm) filled with polar silica gel using a chloroform solvent with increasing methanol concentration. The active fraction was dried under reduced pressure and dissolved in 1 mL of methanol, and introduced into a third column (2 x 95 cm) filled with low molecular gel filtration Sephadex LH-20. Fractions were made in 4 mL portions per minute. The active fractions (tubes 48-60) were mixed and concentrated in a fourth column (1.5 x 8.5 cm) filled with hydrophobic octadecyl silane (ODS) and flown at a concentration gradient of 30 to 70% methanol. Fractionation of 2 mL under mL / min yielded 357 mg of strong antioxidant activity fraction (tubes 10-18).
실험예 4 : 박층크로마토그래피 정제Experimental Example 4 Thin Layer Chromatography Purification
상기 실험예 3의 활성획분을 소량의 메탄올에 용해시켜 극성 실리카겔이 도포된 박층크로마토그라피 플레이트 (20 x 20 cm)에 점적한 후, n-부탄올 : 메탄올 : 물 = 4 : 1 : 2로 구성된 이동용매를 이용하여 전개하고 Rf 값 0.7 위치의 활성띠 부분을 긁어 취한다. 이 성분을 메탄올로 용출하고 소수성 옥타데실란(ODS) 실리카가 도포된 역상플레이트 (20 x 10 cm)에 재점적하여 30% 메탄올을 이동상 용매로 전개하였으며, Rf 0.3 위치의 최종 정제된 맹종죽엽 항산화조성물 108 mg을 획득하였다.After dissolving the active fraction of Experimental Example 3 in a small amount of methanol and dropping onto a thin layer chromatography plate (20 × 20 cm) coated with polar silica gel, n-butanol: methanol: water = 4: 1: 2 Develop with solvent and scrape off the active band at the Rf value of 0.7. This component was eluted with methanol and redeposited on a reversed phase plate (20 x 10 cm) coated with hydrophobic octadecsilane (ODS) silica to develop 30% methanol as a mobile phase solvent, and the final purified dead leaf leaf antioxidant at the Rf 0.3 position. 108 mg of the composition was obtained.
실시예 2 : 맹종죽엽 추출물의 항산화활성 조사Example 2 Investigation of Antioxidant Activity of Extracts from
상기 실시예 1에서 제조된 항산화 활성을 조사하기 위하여 유리 라디컬에 대한 소거활성, 활성산소 소거능 측정, 그리고 지질과산화 저해활성을 각각 측정하였다.In order to investigate the antioxidant activity prepared in Example 1, scavenging activity, free radical scavenging activity, and lipid peroxidation inhibitory activity on free radicals were measured, respectively.
유리라디컬 소거활성은 불로이스의 방법에 준하여 1,1-디페닐-2-피크릴 하이드라질(1,1-diphenyl-2-picryl hydrazyl, DPPH)을 이용하여 측정하였다. 즉 DPPH 20 mg을 에탄올 150 mL에 녹여 DPPH 용액을 만든 후 이 용액 0.5 ml의 메탄올에 용해시킨 시료를 0.1-1 mg/mL 의 농도로 첨가하고 즉시 5초 동안 진탕한 후 10 - 30분 후 동안, 517 nm에서 시료을 가하지 않은 대조군에 대한 흡광도 감소를 유리라디컬소거 활성으로 나타내었다.The free radical scavenging activity was measured using 1,1-diphenyl-2-picryl hydrazyl (1,1-diphenyl-2-picryl hydrazyl, DPPH) according to the method of Bullos. That is, 20 mg of DPPH was dissolved in 150 mL of ethanol to make a DPPH solution, and then a sample dissolved in 0.5 ml of methanol was added at a concentration of 0.1-1 mg / mL, immediately shaken for 5 seconds, and then 10 to 30 minutes later. , The absorbance decrease for the control group without the sample at 517 nm is shown as free radical scavenging activity.
활성산소(superoxide anion) 소거능 측정은 잔틴/잔틴옥시다제 (xanthin/xanthin oxidase) 효소반응에 의한 활성산소 발생계를 이용하여 활성산소에 의한 니트로블루 테트라졸리움 (nitroblue tetrazolim, NBT)의 산화에 의한 광흡수도 (530 nm) 변화를 이용하여 측정하였다.Superoxide anion scavenging activity was measured by photooxidation of nitroblue tetrazolim (NBT) by active oxygen using an active oxygen generator using xanthin / xanthin oxidase enzyme reaction. It was measured using a change in absorbance (530 nm).
지질과산화 저해활성 측정은 적출된 흰쥐 간세포를 초원심분리 (77000g, 60분, Hitachi RP 30) 하여 얻어진 마이크로좀을 지질원으로 하여 Fe2+/아스코르베이트 계에 의한 지질과산화를 유도하고 생성된 말론디알데히드 (malonaldehyde, MDA)를 티오바비트린산 (thiobarbituric acid, TBA)과 반응시켜 시료에 의해 감소된 MDA양을 정량환산하였다. 시험관에 시료가 함유된 간 마이크로좀 용액 200 μL 와 소듐도데실슬폰염 (sodium dodesyl sulfate, SDS) 용액 225 μL를 가하고 5초간 진탕혼합한후, 20%의 아세트산, 75 μL의 증류수, 1.2% TBA 용액 1 mL 씩 가하여 30분간 수욕상에서 가온 하였다. 실온에서 30분 냉각 후에 3000 rpm에서 20분간 원심분리하여 상등액을 532 nm에서 흡광도를 측정하여 시료를 첨가하지 않은 대조군에 대한 지질 과산화 저해활성(%)을 구하였다.Lipid peroxidation inhibitory activity was determined by inducing lipid peroxidation by Fe 2+ / ascorbate system using microsomes obtained by ultracentrifugation (77000g, 60 minutes, Hitachi RP 30) of isolated rat hepatocytes. Malondialdehyde (malonaldehyde, MDA) was reacted with thiobarbituric acid (TBA) to quantify the amount of MDA reduced by the sample. Add 200 μL of the liver microsome solution containing the sample and 225 μL of sodium dodesyl sulfate (SDS) solution to the test tube, shake-mix for 5 seconds, and then add 20% acetic acid, 75 μL distilled water, and 1.2% TBA solution. 1 mL each was added and warmed in a water bath for 30 minutes. After cooling at room temperature for 30 minutes, the supernatant was measured for absorbance at 532 nm by centrifugation at 3000 rpm for 20 minutes to determine the lipid peroxidation inhibitory activity (%) of the control without the sample.
실험예 5 : 유기용매 각 추출물의 항산화활성 측정Experimental Example 5: Determination of antioxidant activity of each extract of organic solvent
상기 실험예 1과 2에서 수득된 에탄올 추출물(1), n-헥산분획(2), 클로로포름분획(3), 에틸아세테이트분획(4), n-부탄올분획(5) 및 최종 수층분획(6)을 1 mg/mL의 농도로 하여 DPPH 유리라디컬소거활성, 활성산소 소거활성 및 지질과산화저해활성을 상기 실시예 2의 방법에 의해 측정하였으며 그 결과를 도 1에 나타내었다.Ethanol extract ( 1 ), n-hexane fraction ( 2 ), chloroform fraction ( 3 ), ethyl acetate fraction ( 4 ), n-butanol fraction ( 5 ) and final aqueous layer fraction ( 6 ) obtained in Experimental Examples 1 and 2 DPPH free radical scavenging activity, active oxygen scavenging activity and lipid peroxidation inhibitory activity at the concentration of 1 mg / mL were measured by the method of Example 2, and the results are shown in FIG.
도 1에 나타낸 바와 같이, 맹종죽엽의 조추출물인 에탄올추출물도 DPPH 유리라디컬소거활성, 활성산소 소거활성 및 지질과산화저해활성이 높아 강한 항산화 활성이 있고, 특히 n-부탄올획분은 탁월한 항산화 효과가 있는 것으로 나타났다.As shown in Fig. 1, ethanol extract, which is a crude extract of the bamboo shoots, also has strong antioxidant activity due to its high DPPH free radical scavenging activity, active oxygen scavenging activity and lipid peroxidation inhibitory activity, and particularly, n-butanol fraction has excellent antioxidant effect. Appeared to be.
실험예 6 : 본 발명에 의한 맹종죽엽 최종 정제획분과 에탄올추출물의 정제효율 비교Experimental Example 6 Comparison of Purification Efficiency of the Final Purified Fraction of Ethanol Extract and Ethanol Extract According to the Present Invention
상기 실험예 4의 박층크로마토그래피 최종 정제 추출물의 정제효율을 확인하기 위하여, 상기 실험예 1과 실험예 4 추출물의 DPPH 유리라디컬소거활성, 활성산소 소거활성 및 지질과산화저해활성을 상기 실시예 2의 방법에 의해 각각 측정하여 그 결과를 표 1에 나타내었다.In order to confirm the purification efficiency of the thin layer chromatography final purified extract of Experimental Example 4, the DPPH free radical scavenging activity, active oxygen scavenging activity and lipid peroxidation inhibitory activity of Experimental Example 1 and Experimental Example 4 extract 2 It was measured by the method of and the results are shown in Table 1.
상기 표 1에서 IC50값의 의미는 50%의 활성을 일으키는 물질의 농도를 의미하는 것이므로 이 값이 낮을수록 항산화활성이 강함을 의미한다. 상기 표1에 나타낸 바와 같이, 맹종죽엽의 최종정제 추출물은 에탄올추출물 보다 DPPH 유리라디컬 소거활성은 약 62 배, 활성산소소거능은 약 200 배, 지질과산화저해활성은 약 33 배 증가된 것으로 나타났다.In Table 1, the IC 50 value means a concentration of a substance that causes 50% of activity, and thus a lower value means a stronger antioxidant activity. As shown in Table 1, the final tablet extract of the dead bamboo leaf leaves showed about 62 times more DPPH free radical scavenging activity, 200 times more active oxygen scavenging activity, and 33 times higher lipid peroxidation activity than ethanol extract.
실험예 7 : 본 발명에 의한 맹종죽엽 정제획분과 종래 항산화제의 항산화활성비교Experimental Example 7 Comparison of Antioxidant Activity of Purified Fractions of Blind Bamboo Leaves according to the Present Invention and Conventional Antioxidants
상기 실험예 4에서 수득된 맹종죽 최종 정제획분과 종래 항산화제와 동일한 조건에서 상기 실시예 2의 방법을 이용하여 DPPH 유리라디컬소거활성, 활성산소 소거활성 및 지질과산화저해활성을 조사하였다. 종래의 항산화제로는 천연항산화제인 알파-토코페롤, 비타민 C, 녹차 항산화성분인 에피갈로카테친 및 기타 천연 항산화성분들인 카페인산, 클로로젠산 및 페룰린산과 합성항산화제인 부틸히드록시톨루엔(BHT)이었다. 비교한 결과는 하기 표 2에 나타내었다.DPPH free radical scavenging activity, active oxygen scavenging activity, and lipid peroxidation inhibitory activity were investigated using the method of Example 2 under the same conditions as the final purified fraction of the bamboo shoot obtained in Experimental Example 4 and the conventional antioxidant. Conventional antioxidants include alpha-tocopherol, vitamin C, epigallocatechin, a green tea antioxidant, and other natural antioxidants, caffeic acid, chlorogenic acid and ferulic acid, and butylhydroxytoluene (BHT), a synthetic antioxidant. . The comparison results are shown in Table 2 below.
상기 표 2에 나타낸 바와 같이, 맹종죽엽 최종 정제 추출물은 비교된 종래의 천연항산화제 및 합성항산화제 보다 우수한 항산화활성을 나타내며, 특히 활성산소 소거능은 매우 강하였다.As shown in Table 2, the final bamboo leaf extract showed a superior antioxidant activity compared to the conventional natural and synthetic antioxidants, especially active oxygen scavenging ability was very strong.
또한 본 발명의 항산화 활성이 맹종죽엽 추출물은 추출과정에서 고온과 강한 빛에서도 그 활성이 변하지 않으므로 열 및 빛에 대한 내성이 강하며, 물에도 잘 용해되므로 수용성 안정 화합물인 것을 알 수 있다.In addition, the antioxidant activity of the present invention is because the activity is not changed even at high temperature and strong light during the extraction process, so the resistance to heat and light is strong, it can be seen that it is a water-soluble stable compound because it is well soluble in water.
이상, 상기 실시예 및 실험예를 통하여 설명한 바와 같이, 본 발명은 종래 폐기되고 있던 맹종죽엽으로부터 항산화할성 특히 활성산소 소거기능이 뛰어난 천연항산화제를 추출하여 국내 농산물의 폐기부위를 고부가가치성 자원화 할 수 있으며, 본 발명의 맹종죽엽 추출물은 천연항산화제이고, 수용성이며 열 및 빛에 강하므로 이를 이용하여 노화 및 성인병 예방 및 치료용 의약조성물, 노화방지용 기능성식품, 기능성 화장품등으로 응용할 수 있어 생물 의약분야 산업상 매우 유용한 발명이다.As described above through the above examples and experimental examples, the present invention extracts natural antioxidants having excellent antioxidant activity, in particular, active oxygen scavenging function, from the dead bamboo leaves, which have been disposed of in the past. Bacterium japonica extract of the present invention is a natural antioxidant, water soluble and resistant to heat and light, so it can be used as a pharmaceutical composition for preventing and treating aging and adult diseases, functional food for anti-aging, functional cosmetics, etc. It is a very useful invention in the field industry.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0055000A KR100486763B1 (en) | 2001-09-07 | 2001-09-07 | Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0055000A KR100486763B1 (en) | 2001-09-07 | 2001-09-07 | Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030021640A true KR20030021640A (en) | 2003-03-15 |
KR100486763B1 KR100486763B1 (en) | 2005-05-03 |
Family
ID=27722956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0055000A KR100486763B1 (en) | 2001-09-07 | 2001-09-07 | Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100486763B1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100447622B1 (en) * | 2001-09-11 | 2004-09-07 | 학교법인고려중앙학원 | Novel chlorogenic acid methyl ether compounds isolated from Phyllostachys edulis leaf and a use thereof |
WO2005120537A1 (en) * | 2004-06-11 | 2005-12-22 | Unigen, Inc. | Composition comprising bamboo extract for androgen agonist |
KR100853714B1 (en) * | 2007-04-05 | 2008-08-25 | 전남대학교산학협력단 | Method for preparing ethanol extracts from bamboo leaves and functional health drinks containing ethanol extracts from bamboo leaves |
KR100913365B1 (en) * | 2007-11-13 | 2009-08-21 | 담양군 | Composition for Removing fatigue |
KR101132636B1 (en) * | 2008-05-27 | 2012-04-02 | 유수진 | Method for Manufacturing Ice-cream Using Bamboo Leaf Tea, and the Ice-cream Obtained Thereby |
US8247007B2 (en) | 2006-10-12 | 2012-08-21 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria |
KR101272793B1 (en) * | 2012-09-21 | 2013-06-10 | 주식회사 래디안 | Cosmetic composition with bamboo leaf ethanol extract and bamboo oil |
US8535735B2 (en) | 2002-03-01 | 2013-09-17 | Unigen, Inc. | Identification of free-B-ring flavonoids as potent COX-2 inhibitors |
US8568799B2 (en) | 2002-03-22 | 2013-10-29 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia |
US8652535B2 (en) | 2002-04-30 | 2014-02-18 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
KR20210095338A (en) | 2020-01-23 | 2021-08-02 | 전남도립대학교산학협력단 | Method for manufacturing functionality reinforced desert cake |
KR20210095329A (en) | 2020-01-23 | 2021-08-02 | 전남도립대학교산학협력단 | Method for manufacturing bamboo macaron using bamboo leaves |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH064851B2 (en) * | 1988-02-19 | 1994-01-19 | 日本油脂株式会社 | Antioxidant |
JPH02173183A (en) * | 1988-12-27 | 1990-07-04 | Nippon Oil & Fats Co Ltd | Antioxidant |
JPH02292206A (en) * | 1989-05-02 | 1990-12-03 | Nippon Oil & Fats Co Ltd | Production of bacteriostatic agent |
-
2001
- 2001-09-07 KR KR10-2001-0055000A patent/KR100486763B1/en not_active IP Right Cessation
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100447622B1 (en) * | 2001-09-11 | 2004-09-07 | 학교법인고려중앙학원 | Novel chlorogenic acid methyl ether compounds isolated from Phyllostachys edulis leaf and a use thereof |
US8535735B2 (en) | 2002-03-01 | 2013-09-17 | Unigen, Inc. | Identification of free-B-ring flavonoids as potent COX-2 inhibitors |
US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
US9168242B2 (en) | 2002-03-22 | 2015-10-27 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia |
US8568799B2 (en) | 2002-03-22 | 2013-10-29 | Unigen, Inc. | Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia |
US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US9849152B2 (en) | 2002-04-30 | 2017-12-26 | Unigen, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
US9655940B2 (en) | 2002-04-30 | 2017-05-23 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US8652535B2 (en) | 2002-04-30 | 2014-02-18 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
JP2008502712A (en) * | 2004-06-11 | 2008-01-31 | ユニジェン インク. | Androgenic composition comprising bamboo or bamboo extract |
WO2005120537A1 (en) * | 2004-06-11 | 2005-12-22 | Unigen, Inc. | Composition comprising bamboo extract for androgen agonist |
KR100720971B1 (en) * | 2004-06-11 | 2007-05-22 | 주식회사 유니젠 | Composition having Bamboo or Bamboo extract for androgen agonist |
US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
US8247007B2 (en) | 2006-10-12 | 2012-08-21 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria |
KR100853714B1 (en) * | 2007-04-05 | 2008-08-25 | 전남대학교산학협력단 | Method for preparing ethanol extracts from bamboo leaves and functional health drinks containing ethanol extracts from bamboo leaves |
KR100913365B1 (en) * | 2007-11-13 | 2009-08-21 | 담양군 | Composition for Removing fatigue |
KR101132636B1 (en) * | 2008-05-27 | 2012-04-02 | 유수진 | Method for Manufacturing Ice-cream Using Bamboo Leaf Tea, and the Ice-cream Obtained Thereby |
KR101272793B1 (en) * | 2012-09-21 | 2013-06-10 | 주식회사 래디안 | Cosmetic composition with bamboo leaf ethanol extract and bamboo oil |
KR20210095338A (en) | 2020-01-23 | 2021-08-02 | 전남도립대학교산학협력단 | Method for manufacturing functionality reinforced desert cake |
KR20210095329A (en) | 2020-01-23 | 2021-08-02 | 전남도립대학교산학협력단 | Method for manufacturing bamboo macaron using bamboo leaves |
Also Published As
Publication number | Publication date |
---|---|
KR100486763B1 (en) | 2005-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101366187B1 (en) | Method of producing proanthocyanid in oligomer | |
Tsai et al. | In vitro antimicrobial activities against cariogenic streptococci and their antioxidant capacities: A comparative study of green tea versus different herbs | |
Policegoudra et al. | Antimicrobial, antioxidant, cytotoxicity and platelet aggregation inhibitory activity of a novel molecule isolated and characterized from mango ginger (Curcuma amada Roxb.) rhizome | |
US20070218146A1 (en) | Lipoxygenase and cyclooxygenase inhibition | |
KR100486763B1 (en) | Extracts of Phyllostachys edulis leaf having antioxidant activity and the process for preparation thereof | |
Zdunić et al. | In vitro hypoglycemic, antioxidant and antineurodegenerative activity of chokeberry (Aronia melanocarpa) leaves | |
KR102026407B1 (en) | A composition for antioxidating comprising extracts of fermented tenebrio molitor | |
US6676978B1 (en) | Method and compositions for producing berry derived products | |
WO2000033670A1 (en) | Method and compositions for producing berry derived products | |
US6423365B1 (en) | Method and compositions producing cherry derived products | |
US20080226758A1 (en) | Lipoxygenase and Cyclooxygenase Inhibition | |
KR20140045688A (en) | Novel antioxidative peptide purified from a marine chlorella ellipsoidea. | |
JP5004265B2 (en) | Sulfur-containing proanthocyanidin oligomer composition and production method thereof | |
KR20160141463A (en) | Anti-oxidation and anti-inflammatory composition comprising the extract of aralia continentalis | |
US20050037130A1 (en) | Method and compositions for producing berry derived products | |
JP2006298800A (en) | Polyphenol having action of fibroblast activation and food supplement and cosmetic containing the same | |
KR100447622B1 (en) | Novel chlorogenic acid methyl ether compounds isolated from Phyllostachys edulis leaf and a use thereof | |
KR102269270B1 (en) | Method for producing extracts of sweet potato with enhanced antioxidative activity | |
KR100585486B1 (en) | Antioxidant composition containing extracts or compounds derived from rubus coreanus | |
KR101963841B1 (en) | Antioxidant composition comprising polyamine compounds isolated from Quercus Mongolica pollen extracts | |
Abdelkarim et al. | Pomegranates bioactive metabolites and biological activities: an updated review | |
WO2022254867A1 (en) | Novel phenylpropanoid compound | |
KR20180071010A (en) | Antioxidant Composition Using an Extract of Polygonum amphibium | |
KR101833422B1 (en) | Antioxidative or antiobesitic composition comprising extract of Alnus firma | |
KR19990033613A (en) | Use of beta-glucogallin compounds as antioxidants and methods for their isolation and purification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130405 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140314 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |